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Introduction
Dose reconstruction for studies of the health effects of ionizing radiation have been carried out for many decades. Major studies have included Japanese bomb survivors, atomic veterans, downwinders of the Nevada Test Site and Hanford, underground uranium miners, and populations of nuclear workers.
For such studies to be credible, significant effort must be put into applying the best science to reconstructing unbiased absorbed doses to tissues and organs as a function of time. In many cases, more and more sophisticated dose reconstruction methods have been developed as studies progressed. For the example of the Japanese bomb survivors, the dose surrogate "distance from the hypocenter" was replaced by slant range, and then by TD65 doses, DS86 doses, and more recently DS02 doses. Over the years, it has become increasingly clear that an equal level of effort must be expended on the quantitative assessment of uncertainty in such doses, and to reducing and managing uncertainty.
In this context, this report reviews difficulties in terminology, explores the nature of Berkson and classical uncertainties in dose reconstruction through examples, and proposes a path forward for Joint Coordinating Committee for Radiation Effects Research (JCCRER) Project 2.4 that requires a reasonably small level of effort for DOSES-2008.
Uncertainty and Error
There are some issues of terminology that should be clarified to ensure clear communication. One issue that has received ever increasing attention is the subject of classical and Berkson errors, and the differing effects each has on the inference of dose-response relationships, power, and confidence intervals. Other issues include shared and unshared errors, covariance over time within an individual's dose history, how uncertainties can be assessed
Terminology: Error and Uncertainty
The International Organization for Standardization has clearly defined metrology terms (International Organization for Standardization (ISO)1995), and these have been adopted by the U.S. National Institute of Standards and Technology (Taylor and Kuyatt1994). The ISO makes careful distinction between the words "error" and "uncertainty."
Error is the "result of a measurement minus the … measurand," where the measurand is the "true value" of the quantity being measured (ISO 1995 B.2.19) .
Uncertainty is the "parameter, associated with the result of a measurement, that characterizes the dispersion of the values that could reasonably be attributed to the measurand" (ISO 1995 B.2.18) . Since the measurand is unknown and unknowable, so is the error. "The result of a measurement (after correction) can unknowably be very close to the value of the measurand (and hence have negligible error) even though it may have a large uncertainty. Thus the uncertainty of the result of a measurement should not be confused with the remaining unknown error" (ISO 1995 3.3.1). The ISO addresses "correction" of measurement results for known systematic deviations inherent in the measurement process.
The ISO (1995) presents methods for assessing combined standard uncertainty to characterize this distribution, including both random and systematic error components. According to the ISO, a Type A uncertainty evaluation is performed by statistical means, such as calculating the standard deviation of a group of repeated measurements. Similarly, a Type B uncertainty evaluation is performed by means other than statistical analysis, such as using expert judgment and process knowledge.
The ISO does not discuss inferences from measurements that result from using measurement results in elaborate models, such as those used in radiation dose reconstruction for health studies.
Some additional considerations of terminology are given in Appendix A.
Two Kinds of Errors: Berkson and Classical
In 1950, Joseph Berkson published a paper that distinguished two conceptually different kinds of errors (Berkson1950). Berkson discussed the effect such errors have on linear regression, giving examples from physics (voltage, current, and resistance in a DC circuit) and controlled toxicology experiments or clinical trials in which a dose of some agent is administered to groups of subjects.
Classical Errors
The first kind of error Berkson describes, now known as a classical error, is the difference between a measured or observed value z and the "true value" of a quantity x. If measurements are repeated with imprecise instruments, different results will be obtained for each measurement. If unbiased, the measurement results will be distributed about the "true value," the measurand. In any case, for classical errors, the "observed" values are distributed about the true value. Classical errors are well understood and are addressed by the ISO (1995) . An uncertainty distribution is a probabilistic, numerical expression of how close the measurand x is likely to be to the observed value z.
Berkson Errors
The second kind of error that Berkson identified is commonly encountered in science, and in dose reconstruction, and has come to be known as a Berkson error. A Berkson error is also a difference between an "observed" value z and a true value x, but with an important distinction: Berkson errors occur when an "observed" value, such as a group mean, is assigned to multiple individuals who have "individual peculiarities" that result in their individual measurands being distributed about the assigned, "observed" value.
Examples of this situation include "an experiment that uses a machine for delivering doses x, which are randomly distributed around the 'dial-setting' z on the machine, the experimenter being free to vary the dial" (Thomas, Stram, and Dwyer1993 ). An example in epidemiology is "an occupational study in which workers with the same job title w are assigned an exposure z based on the mean of area measurements; the true exposures x for individuals with the same job title would differ, but on average would tend to equal the area mean" (Thomas, Stram, and Dwyer1993) . A third example is the use of the same internal dosimetry biokinetic models, such as the ICRP respiratory tract model and a specific plutonium biokinetic model, for a group of workers (Khokhryakov et al.2005) . A final example is the use of the same calculational model, such as that of the ICRP (International Commission on Radiological Protection (ICRP)1996), to infer doses to tissues or organs based on corrected film dosimeter measurements (Smetanin, Vasilenko, and Scherpelz2007) . Berkson (1950) showed that the two types of errors in the independent variable, such as dose or exposure, have different effects on the inference of a dose-response relationship. This analysis has recently been extended (Armstrong1990; Stram and Kopecky2003) . Other analyses have shown intricate effects when models are nonlinear (Thomas, Stram, and Dwyer1993; Armstrong1998; Stram et al.1999; Ron and Hoffman1999; Steenland, Deddens, and Zhao2000; Schafer and Gilbert2006; Kim, Yasui, and Burstyn2006; Küchenhoff, Bender, and Langner2007) .
Effect of Berkson Errors in Radiation Effects Research
Recently, Li et al. (2007) published a Monte Carlo expectation-maximization approach to "analysis of data subject to a combination of classical measurement error and correlated Berkson errors" as originally outlined by Mallick et al. (2002) . This probably represents the state-of-the-art for analysis of such data. Cox and coauthors (1999) and Reeves et al. (1998) have illustrated the effect of classical and Berkson errors on linear regression lines. Their discussion is shown here, and generalized to include Berkson errors that include residual, but unknown, bias.
To understand the effects of classical and Berkson uncertainties, and Berkson uncertainty with residual bias, a thought experiment was undertaken similar to that in Cox et al. (1999) . Figure 1 shows a synthesized dose and response data set, with "true" doses D True ranging from about 50 to 150 (arbitrary units), and a linear response Y True . Random, normally distributed scatter ("noise") has been added to the true response to create Y Noisy . On this and all subsequent graphs, Y Perfect refers to a plot of true responses Y True against true doses D True ., even though the other points and lines are plotted against a different dose variable. Going one step beyond Cox et al. (1999) , Figure 4 shows the same groupings over D True , but with the mean of each group having some residual bias that is shared among all members of each dose group. Bias in the regression line can be towards or away from the null, and is largely driven by the high and low groups. In the case shown below, there is bias away from the null caused by the fact that the highest dose group has been randomly assigned a negative bias, and the lowest dose group has been randomly assigned a positive bias. With many groups and a larger range of doses, such a large bias is unlikely; bias towards the null or no bias are more likely but not certain. Figure 3 , but with residual bias in the group means. This example shows an unusual case of bias away from the null, where the slope of the dose-response curve is actually increased.
The thought experiment illustrated in Figures 1-4 shows the well-established fact that classical and Berkson uncertainties can have different effects on the slope of a regression line of response versus dose. The combination of the two has not been studied. The 15-country nuclear worker study, for example, A limitation of the discussion above and that in Cox et al. (1999) is that doses are in a relatively narrow range, whereas for the Mayak Production Association and the Techa River cohorts, doses span many orders of magnitude. To address this, a second thought experiment was done. Figure 5 shows a hypothetical dose-response data set plotted on a log-log graph. This time there are100 doses ranging from 1 to 1000 (arbitrary units), with 1 being the 0.5 percentile and 1000 being the 99.5 percentile of a lognormal distribution. Such a distribution has a geometric mean dose of 31.6, a geometric standard deviation S G = 3.81, an arithmetic mean of 72, and a standard deviation of 174. A linear response with a slope of 0.01 was generated to yield Y True , and then random noise was algebraically added to Y True . The noise was normally distributed and proportional to the square root of Y True . Figure 6 shows the effect of imposing a more realistic noise (error) distribution on doses. The noise was lognormally distributed with a geometric standard deviation of 2.5, a mean of 1, and random values from that distribution were used to multiply D True . When a uniformly-weighted linear regression is performed of Y on D Noisy ,, the high-dose data dominate the fit, and it is little affected by the lower doses. The resulting line has a positive Y-intercept, and so appears as a curve that has a flat slope at low doses on a log-log plot. When a linear regression is performed of lnY on lnD Noisy , the fit is the expected straight line, but with visible bias towards the null, that is, decreased slope. Continuing the line of reasoning in the first thought experiment, Figure 7 shows the effect of grouping the data into five dose groups with unbiased means. The two though experiments indicate why it is important to distinguish between classical and Berkson uncertainty. Stram and Kopecky (2003) identified shared and unshared components of error. Their notation is mostly used here with the exception that D is reserved for "dose" rather than "disease." For individual i, the true dose D True,i is related to the corrected dose D Corr,i by
Shared and Unshared Errors
1 where ε SM is shared multiplicative error, ε M,i is unshared multiplicative error, ε SA is shared additive error, and ε A,i is unshared additive error. They assume that all ε are independent, with Expectation(ε SM ) = E(ε SM ) = E(ε M,i ) = 1 and E(ε SA ) = E(ε A,i ) = 0. This means that, on the average, D Corr,i is unbiased. It will be necessary to go beyond this unbiased assumption of Stram and Kopecky (2003) , as was shown in the thought experiments above for group doses with residual bias. Thierry-Chef et al. (2007) give "intrinsic sampling variation in measurements inherent to different types of dosimeters, referred to as laboratory error" as an example of "errors that are independent from person to person, and are thus 'unshared.' For these errors, the 'classical error' model applies, in which the estimated values of the input date are assumed to be distributed around the true values of the input data for each subject." By contrast, systematic corrections to dosimetry results are needed to remove bias due to over-or underresponse due to radiation energy and the geometry of irradiation. Such corrections are intended to "produce corrected doses that are, on average, unbiased estimates of the target dose of interest (e.g. organ doses)" (Thierry-Chef et al.2007 ). True doses for individual workers "may differ from the doses obtained by applying the group bias factor" and are thus unshared errors. Under the assumption that the "group bias factors are estimated without error, the group mean doses (after the application of the bias factor) will be correct, and thus these errors follow a Berkson model." Napier (2007; 2008) has drafted an uncertainty proposal for the Techa River Dosimetry System. For each parameter in the Monte Carlo model, Napier identifies whether it is shared (and if so, among whom), and whether it is classical or Berkson.
Work on the Techa River Dosimetry System
Much of the approach to reconstructing doses in the Techa River population differs from the approaches needed for the Mayak worker population. To the maximum extent possible, the two approaches should be coordinated and made to match where possible.
Use of Uncertain Dosimetry Results in Epidemiology
Recently, several authors have reported methods for using uncertain dosimetry data in epidemiology (Stayner et al.2007; Li et al.2007 ). There remain challenges in this area.
Correction Factors
It is necessary to discuss raw dosimetry results and corrections to them. There are measured doses, corrected doses, and "true" doses.
ISO Definitions
The International Organization for Standardization (ISO; 1995) defines an uncorrected result as the result of a measurement before correction for systematic error. A corrected result is the result of a measurement after correction for systematic error. A correction is a value added algebraically to the uncorrected result of a measurement to compensate for systematic error. A correction factor is a numerical factor by which the uncorrected result of a measurement is multiplied to compensate for systematic error.
Discussion of Previous Approaches to Correcting Dosimetry Results
In the paper outlining approaches to managing errors and uncertainties for the "15 Country Study," Thierry-Chef et al. (2007) define a "bias factor" 1 B as
Dose True
In ISO parlance, the "true dose" is not known or knowable, so "conventionally true dose" would be a better term, and adequate for this discussion: If Eqs. 2 and 3 are correct, then B must be the expectation value (arithmetic mean) of the bias factor. But Eq. 4 is only correct if the B i are the geometric mean of the various lognormals. Similarly, the statement "The interval (B/K, B×K) is the 95% confidence interval on the bias factor" clearly implies that B is the geometric mean of the bias distribution. If B is the geometric mean, then Correction Factor in Eq. 6 is less than the geometric mean and cannot be the mean. If B is the arithmetic mean, then Eq. 6 specifies that Correction Factor is the geometric mean. Dividing a Measured Dose by such a Correction Factor would produce, "on the average," a correct "Conventionally True Dose." Equations 2-6 can only be simultaneously true if S is zero and Eq. 6 is simply Correction Factor = B. In that case, the arithmetic mean of a lognormal distribution is equal to the geometric mean. But since the B values given later in the paper, are not equal to 1, the equations cannot all be correct.
This same difficulty, that is, the assumption that the arithmetic mean is equal to the geometric mean for a lognormally-distributed uncertainty, is encountered on page 62 in reference (15) of Thierry-Chef et al., which is the National Research Council book by Masse et al. (1989) : "It should be noted that the mean of the lognormal distribution is a factor of exp(S 2 /2) higher than the median; however, this source of bias is negligible relative to the overall uncertainty and can be safely ignored for most purposes." The method of Masse et al. (1989) was also used by Daniels and Schubauer-Berigan (2005) , but those authors used the method of Fix et al. (2005) This rearrangement results in dividing by the bias factor. When an uncertainty distribution is applied to the bias factor, D Meas is divided by the uncertainty distribution. Dividing by probability distributions is not commonly done because there is no analytical solution for distributions other than the lognormal. It can be shown that there is only one distribution whose reciprocal is the same type of distribution as the original distribution; this is the lognormal. Furthermore, the reciprocal of a lognormal with a geometric mean (median) of 1 is the very same lognormal with the same geometric standard deviation. However, if the mean of the lognormal is taken as 1, then the mean of the reciprocal will not be 1, and using such a distribution in the denominator of an equation injects an unintended additional bias. Thus, dividing by a probability distribution is problematic and is likely to produce counter-intuitive results.
Modification of Previous Approach that Doesn't Assume that the Arithmetic and Geometric Means of a Lognormal Distribution Are Equal
The difficulty of dividing by an asymmetric probability distribution was addressed by Fix et al. (2005) as reported by Scherpelz et al. (2005) and Strom et al. (2005) . That method is reproduced here since it has not been widely published. It is shown here that assuming the arithmetic mean and median (geometric mean) are the same for a lognormally-distributed uncertainty is untenable when geometric standard deviations rise above 2, as they do for neutron doses. Fix et al. (2005) developed point estimates of the various components requiring bias correction factors, and used a variety of sources to develop lognormal uncertainty distributions for the various components of bias, such as radiation energy dependence and irradiation geometry dependence. However, the arithmetic mean of each component's lognormal distribution was set to 1, so that, on average, each component of bias correction was unchanged. When the components were combined by multiplication, the geometric mean (median) of each lognormal distribution was multiplied together to get the geometric mean of the product distribution, and the standard deviations of the natural logarithms of each distribution combined in quadrature to yield the standard deviation of the logs of the product distribution.
The solution to the difficulty of dividing by an asymmetric probability distribution is to define a new bias correction factor (formerly bias factor) B' that is the reciprocal of the bias factor in Eqn. 7 to produce a point estimate of the corrected dose:
When B' is later multiplied by a probability distribution representing uncertainty, the ordinary properties of uncertainty distributions can be applied. An illustration of this correction and the application of an uncertainty distribution to the correction is shown in Figure 9 . For this work, B' represents the ISO correction factor for systematic error, and is comprised of the product of all multiplicative correction factors:
Denoting a lognormal distribution as Λ(μ,σ 2 ), where μ denotes the logarithm of the geometric mean, and σ 2 denotes the square of the logarithm of the geometric standard deviation, it can be shown that the product of two lognormal distributions is lognormal: (Aitchison and Brown 1981) . This property permits relatively simple propagation of uncertainties associated with the various bias components B' i , but does not permit the propagation of other kinds of bias components, such as addition of constants.
A discussion of the application of this method to the calculation of organ doses from external dosimeter readings is given in the Appendix.
Asymmetry of Confidence Intervals about the Mean of a Lognormally-Distributed Variable
A difficulty in this assumption that uncertainties are lognormally distributed arises from a property of the lognormal distribution that is mentioned by Masse et al. (1989) but assumed to be negligible (Masse et al. 1989, p. 52) . When the logarithms of a variable are distributed normally, the central tendency of that distribution is the logarithm of the median (geometric mean), not the expectation value (arithmetic mean) (Aitchison and Brown1981; Strom and Stansbury2000) . The value of the parameter that is needed as input to an epidemiology study is the latter, since it is an unbiased estimator of the parameter. Figure 10 and Table 3 .1. Contrary to the claim in the NRC report (1989) , the mean-to-median ratio is not negligible for geometric standard deviations (S G s) of 2 or more.
For example, in Table 7 of Thierry-Chef et al. (2007) , the largest bias and uncertainty values are for Facility-5, 1943 Facility-5, -1952 . A numerical example using larger S G s is shown in Appendix B. The fact that this correction is not negligible leads to another difficulty. Since we want to use B′ rather than 50 B′ we must account for the fact that the 2.5 %ile and 97.5 %ile points on the distribution are not symmetric about B′ , even though they are symmetric about 50 B′ . This is illustrated in Figure 11 and Figure 12 for a lognormal uncertainty distribution U with an arithmetic mean of 1 and a S G of 3. These figures illustrate that the 2.5% and 97.5% confidence intervals occur at 1.959963 or ~1.96 geometric standard deviations from the geometric mean (median). These are a factor of 96 . 1 G 96 . 1 S K = 15 above or below the median. For a lognormal distribution with a S G of 3, K 1.96 = 8.61.
Because of the asymmetry, the confidence intervals about the mean of a lognormal distribution cannot be expressed by a single factor. Two new factors must be introduced. It is seen in Figures 11 and 12 
Examples of Contributions to Bias Correction and Uncertainty in Dose Reconstruction
There is an extensive body of work on uncertainty in dosimetry and in dose reconstruction, and guidance is currently under development by the U.S. National Council on Radiation Protection and Measurements (NCRP).
Elements Contributing to Bias and Uncertainty for External Dosimetry
Three distinct cases exist for dose reconstruction due to external irradiation: occupational neutrons, occupational photons, and medical exposures. Fix et al. (2005) examined bias and uncertainty in external dosimetry for neutrons, posing 24 questions, as listed in Table 4 .1. These questions are sufficiently generic to apply to Mayak. 
Neutrons
o gamma air absorbed dose/neutron ratios
X-and Gamma Radiation
An analogous list of questions, although somewhat shorter, can be posed for external dosimetry for photons (x-and gamma radiation). While bias correction factors have been developed for the Mayak worker study under JCCRER Project 2.4 (Smetanin, Vasilenko, and Scherpelz2007; Smetanin et al.2007; Vasilenko et al.2007d ), quantitative expressions of uncertainty for these bias factors haven't been developed.
Information in addition to dosimetry results needed to assess uncertainty. There are a variety of sources of such information. Classical uncertainty will be assessed differently for different exposure/measurement groups for many time periods and dose measurement technologies or inference methods. Project 2.4 personnel expect to begin to work out the details during a meeting in late May and early June 2008. JCCRER Project 2.4 researchers had already catalogued and completed assessment of uncertainty for many aspects of the dosimetry in DOSES-2005 (Vasilenko et al.2007c; Khokhryakov et al.2007; Vasilenko et al.2007a; Vasilenko et al.2007b) . Using that notation, additional information should be codified as described below for occupational external photons. Similar approaches are taken for beta, neutron, medical, and internal irradiations. Each approach depends on exposure scenario and year.
For occupational external exposures to photons, consideration must be made of the following points:
• Worker, workplace, and geometry considerations o imputation of photon energy spectrum o imputation of angular exposure distribution by job title (fractions AP, PA, LAT, ROT, ISO) • Air absorbed dose assessment method
where C' γ rec ≡ 1/C γ rec as defined in . Convert dosimeter result D γ arch to air absorbed dose D γ rec using units conversion factors, photon energy spectrum, angular exposure geometry of dosimeter on worker, and dosimeter response characteristics IFK IFK+Pb IFKU Pocket ion chambers Offiste dose reports o convert imputed dose result to air absorbed dose using photon energy spectrum, angular exposure geometry of worker, and dosimeter response characteristics missing values during a monitoring period exposed but unmonitored workers for whom doses are inferred from measurements on co-workers exposed but unmonitored workers for whom doses are inferred from dose rate measurements and stay-times exposed but unmonitored workers for whom doses are inferred from process knowledge and stay-times • D γ org-i = C γ org-i × D γ rec Conversion of air absorbed dose to organ dose o imputation of photon energy spectrum o imputation of angular exposure distribution by job title o calculation of organ doses • Uncertainties in C γ org-i , C' γ rec , and C γ dos are expressed as lognormal distributions with arithmetic means and geometric standard deviations as described in the Uncertainty Proposal. The values of the arithmetic means and geometric standard deviations are based on analysis of the factors considered above, much of which has already been done. Sensitivity analysis, e.g., Monte Carlo simulation of distributions using different worker and dosimeter exposure geometries, different photon spectra, variability in calibration curves, etc., can inform these choices.
Medical Radiation Exposures
Unlike x-and gamma radiation, reconstructing doses from medical radiation is not done on the basis of individual dosimetry. Rather, it is based on a review of a worker's medical records for dates and kinds of exams, or, with less confidence, review of standard procedures at a plant regarding the kind and frequency of medical radiology exams during a worker's time at the plant.
Many factors that affect the dose to tissues or organs from medical radiography have been identified (Strom and Martin2004) . These are listed, along with multiplicative ranges of observed dose, in Table 4 .2. Measurements on existing equipment can dramatically reduce uncertainty, but measurements don't apply to individuals and thus individual variability still remains. The existence of a usable film places limits on some parameters, but doesn't tell about collimation, filtration, film/screen, retakes, or patient thickness.
Intakes of Radionuclides
For doses resulting from intakes of radionuclides, the important factors have been outlined in several recent papers (Bess et al.2007; Etherington et al.2006; Krahenbuhl et al.2005) . Bayesian approaches to uncertainty are planned as well (Romanov et al.2007 ). Classification of uncertainty into shared and unshared components, as well as into classical and Berkson components, probably still remains to be done.
Residual Systematic Error
When bias corrections have been made as well as can be done, given uncertain knowledge of all the variables that contribute to bias, the resulting B' may differ systematically from the value B' True that would yield D True :
The residual bias is shared by those individuals for whom it applies, but not by others. Residual, uncorrected bias is likely to differ for differing job titles, different work locations, and different years (e.g., as shielding or ventilation was installed to lower doses and intakes, work practices evolved to reduce doses, personal protective equipment introduced, etc.). Residual uncorrected bias is not discussed in any analyses of Berkson errors known to this author. Current authors are likely to state, "…if the group bias factors are estimated without error, the group mean doses (after application of the bias factor) will be correct, and thus these errors follow a 'Berkson' error model" The fact that the residual uncorrected bias is unknown leads to a need to estimate its magnitude, which must be done by a Type B uncertainty analysis.
Error, Variability, and Uncertainty
It is clear that variability in characteristics of individuals, such as height, weight, metabolism, diet, lifestyle, work habits, and behaviors lead to individual differences from group means. If the true, unbiased group mean is known, then one can label these differences "errors" in the ISO sense of a difference between a measurand and a corrected measurement value. From the perspective of dose reconstruction for health effects research, such differences must be estimated and recorded as uncertainties.
Intra-individual Covariance of Annual Doses over Time
André Bouville recently shared his "Rules for Dosimetry for Epidemiology," which include "cooperate with the epidemiologists, calculate the annual absorbed dose to the organ of interest, give preference to measurements on individual subjects, ask the right questions during interviews, validate data and doses to eliminate bias, and estimate uncertainties as well as possible" (Strom2007). Often health effects studies do require annual organ doses.
For the case of intakes of radionuclides that are tenaciously retained in the body, such as plutonium, americium, and strontium, uncertainties in corrected annual doses will be very highly correlated. The uncertainty of the sum of such annual doses, that is, corrected dose cumulated to some specified date, must be calculated with this covariance in mind.
Likewise, uncertainties in corrected annual external dosimetry results for individuals will show some correlation over time for each individual. The uncertainty of the sum of such annual doses, that is, corrected dose cumulated to some specified date, must also be calculated with this covariance in mind.
A Proposal for a Numerical Expression of Uncertainty in Results of Dose Reconstruction to Be Applied Throughout JCCRER Project 2.4
It is proposed that, for each individual i, each corrected annual dose in year y to a tissue or organ T, D Corr,C,T (i,y) be accompanied by expressions of uncertainty that are divided into classical and Berkson components, and that covariance among components of dose over an individual's lifetime be included in the assessment of uncertainty in lifetime dose.
Measurements on individual subjects include film badge results, bioassay results, and autopsy data. Each of these has associated measurement uncertainty that is a combination of random and systematic uncertainties. The uncertainties will be treated as a combined standard uncertainty following the ISO procedure (ISO 1995).
Groups of individuals have corrected doses that are calculated by application of the same bias correction factors. All members in such groups share the uncertainty in those factors, including the residual uncorrected bias. True doses to individuals in the group may differ systematically from the bias corrected doses. Such Berkson errors become uncertainties when the dose is assigned to individuals.
Specific Proposal for DOSES2008: The Dose-Uncertainty Vector
For each individual i, each corrected annual dose (in dose category C) in year y to a tissue or organ T, the corrected dose D Corr,C,T (i,y) will have 5-part numerical expression of uncertainty. The combination of these variables is called a dose-uncertainty vector.
Six Dose Categories
For DOSES2008, it is proposed that separate files of D Corr,C,T (i,y) be created and maintained for 1) low-LET gamma external occupational doses; 2) low-LET beta external occupational doses; 3) low-LET (neutron) external occupational doses; 4) high-LET (neutron) external occupational doses; 5) internal occupational doses; and 6) medical doses.
Component 1: The Corrected Annual Dose D Corr,C,T (i,y)
The dose value itself is the best corrected dose estimate, that is, the expectation value of the true dose given all that is known about the individual, the measurements on that individual, the workplace, and the measurements made in the workplace. The value recorded for D Corr is not a geometric mean, but an arithmetic mean. Work to create D Corr,C,T (i,y) values is well underway for all 5 categories of dose.
Component 2: The Magnitude of the Uncertainty, S G
For reasons described in Sections 3.3 and 3.4, the uncertainty is a lognormal distribution with an arithmetic mean of 1 and a geometric standard deviation S G determined as outlined below.
Component 3: Apportionment of the Variance in Dose Uncertainty, f Classical
The variance of this lognormal distribution is The dose reconstruction team will create a variable f Classical equal to the fraction of this variance that is due to classical uncertainty. Implicitly, the balance of the variance is ascribed to Berkson uncertainty.
Components 4 and 5: Covariance Over Time Expressed as a Correlation Coefficient r 2 (y) and Correlation Start Year y Crlt (y)
A complete covariance matrix of all of an individual's annual doses is impractical and unwieldy, and probably exceeds the needs of the epidemiologists at this point in our analyses.
In its place, it is proposed to use the correlation coefficient r 2 (y) and a second variable, the year that the correlation ("Crlt") started y Crlt (y). Implicit in this structure is the idea that correlation of systematic bias will be constant over a particular dosimeter type (IFK, IFK+Pb, IFKU), a particular x-ray machine and technique, a particular job title that would be correlated with radiation fields or characteristics of a plutonium aerosol, and so on. For example, an r 2 of 0.3 might be assigned to all of a single worker's dosimetry results that were based on IFK dosimeter results, and would apply over all years during which that individual used an IFK dosimeter.
It remains to be clarified whether and how correlation should be handled separately for classical and Berkson uncertainties, and for unshared and shared uncertainties.
The 5-Component Dose-Uncertainty Vector
Each dose-uncertainty vector consists of 5 components for each of the 5 categories of dose: [D Corr,C,T (i,y), S G , f Classical , r 2 (y), y Crlt (y)].
What Is Not Included in the Dose-Uncertainty Vector
The existing papers on Berkson uncertainties do not recognize the possibility that individuals may be in one Berkson grouping for a period of time, and then migrate to another Berkson grouping. In fact, any time a worker changes job titles, he or she is leaving one Berkson grouping and entering another, if the new job title has a different energy spectrum of photons or neutrons. Similarly, everyone having chest xrays taken with one machine might have a component of Berkson uncertainty for that machine, while those who later have chest x-rays taken with another machine would have a component of Berkson uncertainty associated with that machine. Different dosimeter technologies will each be associated with one or more Berkson groupings of uncertainty. In works like that of Thierry-Chef et al. (2007) , there are many categories of Berkson uncertainty, but it isn't clear how the memberships and nature of these categories change over time.
Using the same calculational dosimetry model, e.g., the Reference Man phantom used in ICRP Publication 74, for all workers when workers have individual differences from Reference Man should result in Berkson errors for individuals if Reference Man is correct on average for the population. The assumption that, on average, the Berkson error is ± (δ = 0) or ×÷ (ε = 1) has been made in all papers on the subject. However, if Reference Man is wrong on average for the population, a systematic error has been made, on the average, for everyone in the population. This error biases each individual's Berkson error so that it is + (δ + b) and
. Every effort is made to remove such bias.
How one would assess residual bias that cannot be assessed or removed is unknown. If one can assess it, one removes it. If one cannot assess it, then it's anyone's guess how large it may be.
Thus, the questions of "With whom is a particular Berkson grouping shared?" and "For how long is a particular Berkson grouping shared?" are not included in the dose-uncertainty vector proposed here. This may be a critical flaw, but developing a method to create and store this kind of information is a completely intractable problem at this point in the project. It could be true that, if Berkson groupings have few individuals, and the individuals change fairly often, that the effect of Berkson groupings on the doseresponse relationship and its confidence intervals will have to be reevaluated.
Re-evaluation may be needed if individuals often change Berkson groups, and only small proportions of the population are in any single Berkson group at one time. It is unclear whether Berkson errors in this case would have the same effect as classical uncertainties. The rationale for this supposition comes from a thought experiment in which an extreme situation results in the total membership of each Berkson group being 1 individual. The transition from everyone being in a Berkson group to having several Berkson groups to having many Berkson groups to having a different Berkson "group" for each individual (i.e., no two individuals in the same group) would seem to make the distinction between Berkson and classical uncertainties disappear. Furthermore, even with Berkson groups with several or even many members, if individuals move in and out of the groups, it may be difficult to see the same effect.
Specifically, for Mayak workers, an individual would be a member of one Berkson group based on job title, another based on work location, a third based on dosimeter type, a fourth based on the years during which various radiation protection measures were or were not present in his or her work location (i.e., shielding or containment or ventilation may have been introduced in one area sooner than in another area). To the extent that individuals changed job titles, membership would shift to some different Berkson groups.
Finally, the currently proposed dose-uncertainty vector does not adequately deal with the possibility of zero or negative doses. This is discussed in Appendix C.
Determining the Uncertainty Parameters of the Dose-Uncertainty Vector
Due to limitations on time, resources, knowledge, and the utility of this approach to the epidemiologists, it is proposed that an expert-elicitation process be used to determine S G , f Classical , r 2 (y), y Crlt (y) for DOSES2008. Refinements of this process must await future funding. The expert-elicitation process will include discussions during meetings, exchanges of electronic mail, and telephone communications. The process will consider all previous work on uncertainties in doses for radiation health studies, with particular emphasis on products of Project 2.4 such as Krahenbuhl et al. (2005) and Zharov et al. (Zharov et al.2007 ).
It is envisioned that the dose-uncertainty vectors may be fairly simple for DOSES2008, with categories for various times and conditions. A conceptual idea of the uncertainty portion of the dose-uncertainty vectors can be seen in Table 3 
Use of the Dose-Uncertainty Vector
The existence of a unique dose-uncertainty vector for each annual tissue or organ dose, in the 3 categories of external occupational, internal occupational and medical doses, provides new opportunities for biostatisticians and epidemiologists.
Cumulating Organ or Tissue Doses Up to a Certain Year
The dose-uncertainty vectors for each of the 4 dose categories permits analysts to • add doses up to a certain year, such as 5 or 10 years before the diagnosis of a cancer • create an numerical expression of the uncertainty of that dose • determine the fraction of the variance in the dose that is due to classical and Berkson uncertainty • know that uncertainty correlation over years has been adequately accounted for
Uncertainty Propagation for Cumulated Organ or Tissue Doses
Explicit algorithms will be developed by the Project 2.4 team in cooperation with Project 1.1 and our customers, the epidemiologists and biostatisticians. Such algorithms will result in a cumulated doseuncertainty vector for each of the 4 categories of dose, but without r 2 (y) and y Crlt (y) since these will have been used to develop the S G and f Classical values.
Proposed Milestones for the Uncertainty Task
Proposed milestones for the uncertainty task are given in Table 4 . 
Level of Effort
A draft level of effort proposal appears in Table 5 . There are numerous issues regarding terminology that is used differently in different disciplines. For dosimetry, some of the issues to be sorted out are shown in Table 6 . Sometimes the word "error" is used when "uncertainty" is intended, at least in the ISO GUM meaning of "uncertainty" (International Organization for Standardization (ISO)1995).
There is concern about shared versus unshared uncertainty, about Berkson versus classical uncertainty. Careful attention must be given to the correct usage of these terms both in English and in Russian.
Appendix B: Propagation of Uncertainty for Lognormally-Distributed Correction Factors
In studies of the health effects of ionizing radiation, it is often necessary to remove bias in the dose variable by correcting dosimetry measurements. When such corrections are lognormally distributed and multiplicative, as in Thierry-Chef et al. (2007) or Masse et al. (1989) , care must be used in propagating uncertainty.
This paper presents an argument that correction factors are the arithmetic means of lognormal distributions. Any other interpretation, such as the reasoning following Eq. (11) in Schafer and Gilbert (2006) , results in biased corrected dose values.
Note that in this presentation of the problem, corrected dose values are products of correction factors and measured doses, while in Thierry-Chef et al. (2007) or Masse et al. (1989) , one must divide by correction factors. Dividing by probability distributions is less intuitive than multiplying by them, and leads to difficulties if they have any nonzero probability at zero or negative numbers.
Point Estimates
Consider a dosimeter such as a simple film badge that produces a reading D Meas which is a reasonably accurate dose to a dosimeter that is calibrated with a particular energy spectrum of gamma radiation in a particular irradiation geometry, e.g., normal to the dosimeter.
Suppose A is a correction for energy response of the dosimeter for anterior-posterior (AP) irradiation so that the product AD Meas is the correct dose to air for AP irradiation in the energy spectrum of gamma radiation to which the worker was exposed, as opposed to the energy spectrum of the calibration radiation. Suppose B is a correction for the angular response of the dosimeter at that energy for the irradiation geometry in which it was believed to have been exposed (e.g., 50% AP and 50% rotational), so that the product ABD Meas is the air dose corrected for angular response. Suppose C is a correction from air dose to tissue or organ dose so that the product ABCD Meas is the correct tissue or organ dose.
Suppose one wants to apply correction factors A, B, and C to a measured dose D Meas in such a way that, on the average, D Corr will be unbiased. If one does a deterministic calculation, 
Normally-Distributed Correction Factors
Now suppose that A, B, and C are uncertain, and are normally distributed. The results for these four thought experiments are found in Table 7 .
General Procedure for Propagating Lognormally Distributed Uncertainties
If multiplicative correction factors A i are unbiased, on the average, and are found to be lognormally distributed, then the correct propagation of uncertainty is to find the lognormal distribution whose arithmetic mean i A is equal to the correction factor. The parameters of this lognormal distribution are the geometric mean A GM,i and geometric standard deviation S G,i . The former is 2 / ) (ln GM, The arithmetic mean of the multiplicative correction factors is simply the product of their arithmetic means:
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This result corresponds to the point estimate case and the normal distribution case. Under some circumstances, it may be necessary to admit the possibility that an uncertain dose may be zero. Under other circumstances, such as a low value of a bioassay measurement, there is a relatively large measurement uncertainty that includes zero and negative values. In these circumstances, a purely lognormal expression for uncertainty is inadequate.
While neither a negative dose nor a negative activity has physical meaning, the difference between two doses or the difference between two activities can meaningfully be negative. An individual who receives a series of doses that are small compared to the measurement uncertainty can legitimately have a record of small positive and small negative results.
If some components of uncertainty are lognormally distributed and combined as described above, and a component of uncertainty corresponding to measurement error that is normally distributed with a mean of 0, then the resulting distribution may be a sum of a normal distribution and a lognormal distribution.
Consider the case of D Corr Energy Angle Organ = 24, as in Appendix B. If, in addition to the correction factors A, B, and C, suppose the original D Meas = 1 was characterized by a normal distribution with a mean of 0 and a standard deviation of 2 as shown in Figure 13 . Admittedly, this is a case in which D Meas would be regarded by many as not significantly different from 0, but it illustrates the problem well. Also, the geometric standard deviation of the correction factors is larger than is likely for most kinds of measurements, but it is chosen to illustrate an extreme case.
In this example, the normal uncertainty is a classical uncertainty, and the correction factor uncertainty is almost entirely a Berkson uncertainty.
Of course, a negative dose is not physically meaningful 3 . However, setting spurious negative doses to zero without equally compensating for equally spurious positive doses injects a positive bias into sums or averages of doses.
Unlike the distribution of the product of lognormal distributions discussed in the main text and in Appendix B, the result of convolving the normal and lognormal distributions is a hybrid distribution that has no known analytical expression.
One may wish for example to compute an annual dose from a series of monthly dosimeter results. If one adds doses with such hybrid uncertainty distributions, the classical measurement uncertainties will tend to cancel out, since the classical uncertainties are expected to be independent. The Berkson uncertainties will not diminish with addition. The shape and characteristics of the resultant sum distribution are not known at this time, but research is currently underway to characterize such a distribution. Since it is probable that for reasonable dose characterization for epidemiology, dramatic simplifications will be needed, the adequacy of approaches to simplification is being studied, and manuscripts prepared for publication.
